Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 170 entries
View as:

A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of CHF6297 in Healthy Subjects and Patients With COPD

Phase: N/A Priority: Normal
NCT ID: NCT02815488 Org: User:
Start: 01/22/16 End: 03/31/19 Due: 03/31/20

Lung Deposition of Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium Bromide Administered Via pMDI in Healthy, Asthmatic and COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT02975843 Org: User:
Start: 11/21/16 End: 04/11/17 Due: 04/11/18

Foster With or Without Charcoal Block or Aerochamber Plus

Phase: N/A Priority: Normal
NCT ID: NCT01280175 Org: User:
Start: 12/31/06 End: 02/28/07 Due: 02/28/08

Drug-drug Interaction Study of CHF5993 With Cimetidine

Phase: N/A Priority: Normal
NCT ID: NCT02287272 Org: User:
Start: 05/31/14 End: 09/30/14 Due: 09/30/15

AssessmenT of smalL Airways involvemeNT In aSthma (ATLANTIS)

Phase: N/A Priority: Normal
NCT ID: NCT02123667 Org: User:
Start: 06/30/14 End: 03/04/17 Due: 03/04/18

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis

Phase: N/A Priority: Normal
NCT ID: NCT06166056 Org: User:
Start: 11/29/23 End: 06/30/25 Due: 06/30/26

Lung Deposition of the BDP/Formoterol Combination Administered Via the NEXT DPI in Healthy, Asthmatic and COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT01176747 Org: User:
Start: 08/31/10 End: 10/31/10 Due: 10/31/11

Pharmacokinetics of CHF 5993 pMDI With and Without Spacer in COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT02119234 Org: User:
Start: 03/31/14 End: 02/28/15 Due: 02/28/16

Efficacy of LAMA Added to ICS in Treatment of Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02296411 Org: User:
Start: 11/30/14 End: 08/31/15 Due: 08/31/16

A Study to Evaluate the Acute Bronchodilator Effect of CHF1535 NEXThaler

Phase: N/A Priority: Normal
NCT ID: NCT02148120 Org: User:
Start: 04/30/14 End: 10/31/14 Due: 10/31/15

FACTO Study (Foster® As Complete Treatment Option)

Phase: N/A Priority: Normal
NCT ID: NCT00901368 Org: User:
Start: 05/31/09 End: 12/31/10 Due: 12/31/11

Efficacy and Safety of Glycopyrrolate Bromide of COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT02189577 Org: User:
Start: 06/30/14 End: 02/28/15 Due: 02/28/16

CHF6563 in Babies With Neonatal Opioid Withdrawal Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT04104646 Org: User:
Start: 12/18/20 End: 12/13/21 Due: 12/13/22

Study to Evaluate Efficacy/Safety of 4 Doses of CHF5259 Via Dry Powder Inhaler (DPI) in Patients With COPD

Phase: N/A Priority: Normal
NCT ID: NCT02680197 Org: User:
Start: 02/29/16 End: 02/06/17 Due: 02/06/18

A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®

Phase: N/A Priority: Normal
NCT ID: NCT00885365 Org: User:
Start: 04/30/09 End: 05/31/10 Due: 05/31/11

Safety and Efficacy Study of Treatment With Single Doses of CHF 4226 pMDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00782535 Org: User:
Start: 12/31/08 End: 03/31/09 Due: 03/31/10

Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic Children

Phase: N/A Priority: Normal
NCT ID: NCT01658891 Org: User:
Start: 02/28/14 End: 02/29/16 Due: 02/28/17

A Study Comparing the Pharmacokinetic, Pharmacodynamic and Safety of CHF 1535 (Fixed Combination of Beclomethasone + Formoterol) Administered Via the NEXT DPI, Versus the Free Combination of Licenced Beclomethasone DPI and Formoterol DPI in Asthmatic Adolescent and Adult Patients.

Phase: N/A Priority: Normal
NCT ID: NCT01191424 Org: User:
Start: 10/31/10 End: 09/30/11 Due: 09/30/12

An Open Label Placebo Study to Assess the Inhalation Profile in Asthmatic Patients Using the Nexthaler® Dry Powder Inhaler (DPI) Device

Phase: N/A Priority: Normal
NCT ID: NCT01651650 Org: User:
Start: 06/30/12 End: 09/30/12 Due: 09/30/13

A Study to Investigate Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of CHF6333 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03056326 Org: User:
Start: 11/30/16 End: 07/31/17 Due: 07/31/18

Randomized Cross Over Study to Assess Efficacy and Safety of BDP/FF and Glycopyrrolate

Phase: N/A Priority: Normal
NCT ID: NCT01476813 Org: User:
Start: 03/31/12 End: 07/31/13 Due: 07/31/14

A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa

Phase: N/A Priority: Normal
NCT ID: NCT06917690 Org: User:
Start: 04/18/25 End: 09/30/29 Due: 09/30/30

Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD

Phase: N/A Priority: Normal
NCT ID: NCT00476099 Org: User:
Start: 12/31/06 End: 11/30/08 Due: 11/30/09

A Study Comparing the Efficacy and Safety of CHF 1535 (BDP +FF) Inhalation Powder, Administered Via the NEXT Inhaler, Versus CHF 1535 (BDP +FF), Administered Via a pMDI, in Moderate to Severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00862394 Org: User:
Start: 02/28/09 End: 01/31/10 Due: 01/31/11

Study on Patterns of Care in Mild Asthmatic Patients

Phase: N/A Priority: Normal
NCT ID: NCT04598555 Org: User:
Start: 02/25/21 End: 09/02/22 Due: 09/02/23